| Detection and localization of surgically resectable cancers with a multi-analyte blood test JD Cohen, L Li, Y Wang, C Thoburn, B Afsari, L Danilova, C Douville, ... Science 359 (6378), 926-930, 2018 | 2675 | 2018 |
| Organoid profiling identifies common responders to chemotherapy in pancreatic cancer H Tiriac, P Belleau, DD Engle, D Plenker, A Deschênes, TDD Somerville, ... Cancer discovery 8 (9), 1112-1129, 2018 | 951 | 2018 |
| Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers JD Cohen, AA Javed, C Thoburn, F Wong, J Tie, P Gibbs, CM Schmidt, ... Proceedings of the National Academy of Sciences 114 (38), 10202-10207, 2017 | 578 | 2017 |
| Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis QP Janssen, S Buettner, M Suker, BR Beumer, P Addeo, P Bachellier, ... JNCI: Journal of the National Cancer Institute 111 (8), 782-794, 2019 | 326 | 2019 |
| Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma VP Groot, G Gemenetzis, AB Blair, RJ Rivero-Soto, J Yu, AA Javed, ... Annals of surgery 269 (6), 1154-1162, 2019 | 310 | 2019 |
| Benchmarks in pancreatic surgery: a novel tool for unbiased outcome comparisons P Sánchez-Velázquez, X Muller, G Malleo, JS Park, HK Hwang, N Napoli, ... Annals of surgery 270 (2), 211-218, 2019 | 281 | 2019 |
| Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer B Lee, L Lipton, J Cohen, J Tie, AA Javed, L Li, D Goldstein, M Burge, ... Annals of Oncology 30 (9), 1472-1478, 2019 | 197 | 2019 |
| Risk factors and mitigation strategies for pancreatic fistula after distal pancreatectomy: analysis of 2026 resections from the international, multi-institutional distal … BL Ecker, MT McMillan, V Allegrini, C Bassi, JD Beane, RM Beckman, ... Annals of surgery 269 (1), 143-149, 2019 | 191 | 2019 |
| Is a pathological complete response following neoadjuvant chemoradiation associated with prolonged survival in patients with pancreatic cancer? J He, AB Blair, VP Groot, AA Javed, RA Burkhart, G Gemenetzis, ... Annals of surgery 268 (1), 1-8, 2018 | 175 | 2018 |
| Circulating tumor DNA as a clinical test in resected pancreatic cancer VP Groot, S Mosier, AA Javed, JA Teinor, G Gemenetzis, D Ding, ... Clinical Cancer Research 25 (16), 4973-4984, 2019 | 168 | 2019 |
| Characterization and optimal management of high-risk pancreatic anastomoses during pancreatoduodenectomy BL Ecker, MT McMillan, HJ Asbun, CG Ball, C Bassi, JD Beane, ... Annals of surgery 267 (4), 608-616, 2018 | 168 | 2018 |
| Modified staging classification for pancreatic neuroendocrine tumors on the basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems G Luo, A Javed, JR Strosberg, K Jin, Y Zhang, C Liu, J Xu, K Soares, ... Journal of Clinical Oncology 35 (3), 274-280, 2017 | 158 | 2017 |
| Circulating tumor cells dynamics in pancreatic adenocarcinoma correlate with disease status: results of the prospective CLUSTER study G Gemenetzis, VP Groot, J Yu, D Ding, JA Teinor, AA Javed, LD Wood, ... Annals of surgery 268 (3), 408-420, 2018 | 155 | 2018 |
| Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas G Gemenetzis, F Bagante, JF Griffin, N Rezaee, AA Javed, LL Manos, ... Annals of surgery 266 (2), 339-345, 2017 | 122 | 2017 |
| Negative pressure wound therapy for surgical-site infections: a randomized trial AA Javed, J Teinor, M Wright, D Ding, RA Burkhart, J Hundt, JL Cameron, ... Annals of surgery 269 (6), 1034-1040, 2019 | 121 | 2019 |
| Implications of the pattern of disease recurrence on survival following pancreatectomy for pancreatic ductal adenocarcinoma VP Groot, G Gemenetzis, AB Blair, D Ding, AA Javed, RA Burkhart, J Yu, ... Annals of surgical oncology 25, 2475-2483, 2018 | 110 | 2018 |
| Tumor-vessel relationships in pancreatic ductal adenocarcinoma at multidetector CT: different classification systems and their influence on treatment planning AM Zaky, CL Wolfgang, MJ Weiss, AA Javed, EK Fishman, A Zaheer Radiographics 37 (1), 93-112, 2017 | 107 | 2017 |
| The comprehensive complication index (CCI®) is a novel cost assessment tool for surgical procedures RD Staiger, M Cimino, A Javed, S Biondo, C Fondevila, J Périnel, ... Annals of surgery 268 (5), 784-791, 2018 | 102 | 2018 |
| Patient-derived organoid pharmacotyping is a clinically tractable strategy for precision medicine in pancreatic cancer TT Seppälä, JW Zimmerman, E Sereni, D Plenker, R Suri, N Rozich, ... Annals of surgery 272 (3), 427-435, 2020 | 96 | 2020 |
| Genetic analysis of small well-differentiated pancreatic neuroendocrine tumors identifies subgroups with differing risks of liver metastases A Pea, J Yu, L Marchionni, M Noe, C Luchini, A Pulvirenti, RF De Wilde, ... Annals of surgery 271 (3), 566-573, 2020 | 96 | 2020 |
Christopher L.WolfgangNYU Grossman School of MedicineZweryfikowany adres z NYULangone.org
